Literature DB >> 23760348

[Nutrition and acute respiratory failure].

M Hecker1, T W Felbinger, K Mayer.   

Abstract

Acute respiratory distress syndrome (ARDS) is characterized by the formation of a protein-rich alveolar edema caused by increased permeability of the alveolocapillary membrane. The key clinical feature is refractory arterial hypoxemia, which in severe cases necessitates the application of extracorporeal membrane oxygenation. Besides lung-protective ventilation as a confirmed therapeutic option, supportive therapy is an integral part of ARDS management. In this context, modern and individualized nutritional regimens are of special importance; however, their prognostic impact, especially of immunonutrition, for ARDS patients is controversial. In this review, basic features of nutrition in intensive care medicine and ARDS-specific aspects (e.g., immunonutrition) are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760348     DOI: 10.1007/s00063-012-0199-6

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  31 in total

1.  [Acute respiratory distress syndrome].

Authors:  M Hecker; M A Weigand; K Mayer
Journal:  Internist (Berl)       Date:  2012-05       Impact factor: 0.743

2.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

3.  Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis.

Authors:  U Suchner; D P Katz; P Fürst; K Beck; T W Felbinger; U Senftleben; M Thiel; A E Goetz; K Peter
Journal:  Crit Care Med       Date:  2001-08       Impact factor: 7.598

4.  ESPEN Guidelines on Enteral Nutrition: Intensive care.

Authors:  K G Kreymann; M M Berger; N E P Deutz; M Hiesmayr; P Jolliet; G Kazandjiev; G Nitenberg; G van den Berghe; J Wernerman; C Ebner; W Hartl; C Heymann; C Spies
Journal:  Clin Nutr       Date:  2006-05-11       Impact factor: 7.324

5.  Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.

Authors:  J E Gadek; S J DeMichele; M D Karlstad; E R Pacht; M Donahoe; T E Albertson; C Van Hoozen; A K Wennberg; J L Nelson; M Noursalehi
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

6.  Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury.

Authors:  Todd W Rice; Arthur P Wheeler; B Taylor Thompson; Bennett P deBoisblanc; Jay Steingrub; Peter Rock
Journal:  JAMA       Date:  2011-10-05       Impact factor: 56.272

Review 7.  [Nutrition in intensive care medicine: Part 2: special nutritional problems].

Authors:  M Hecker; T W Felbinger; K Mayer
Journal:  Anaesthesist       Date:  2013-03       Impact factor: 1.041

Review 8.  Acute lung injury and the acute respiratory distress syndrome: a clinical review.

Authors:  Arthur P Wheeler; Gordon R Bernard
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

9.  ESPEN Guidelines on Parenteral Nutrition: intensive care.

Authors:  Pierre Singer; Mette M Berger; Greet Van den Berghe; Gianni Biolo; Philip Calder; Alastair Forbes; Richard Griffiths; Georg Kreyman; Xavier Leverve; Claude Pichard
Journal:  Clin Nutr       Date:  2009-06-07       Impact factor: 7.324

Review 10.  Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective.

Authors:  Pierre Singer; Haim Shapiro; Miryam Theilla; Ronit Anbar; Joelle Singer; Jonathan Cohen
Journal:  Intensive Care Med       Date:  2008-05-07       Impact factor: 17.440

View more
  1 in total

Review 1.  [Diagnosis and therapy of an acute abdomen].

Authors:  A Hecker; B Hecker; K Kipfmüller; J Holler; E Schneck; M Reichert; M A Weigand; W Padberg; M Hecker
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-09       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.